We are proud to announce that one of our portfolio companies, QurAlis, has successfully completed Phase 1 trials for a drug they are developing to treat ALS and epilepsy! This is a great milestone for the company and the pharmaceutical industry in general in making steps to better combat these diseases. Congrats to the QurAlis team! https://lnkd.in/etTQX7he Kasper Roet Sunao Nishimura Masaji Matsuoka Kazufumi Nakamura Yukitaka Kojima, CFA Kinji Fuchikami Toshihiro Terada Yuji Fukuda Orie Schneider Sue Yasuko Nagakura Makiko Kikuchi Aya Runderkamp
Mitsui & Co. Global Investment, Inc.
风险投资与私募股权管理人
Menlo Park，California 298 位关注者
一家帮助初创企业在全球取得成功的风险投资公司。
关于我们
在三井物产环球投资，我们对最先进的技术和科学突破感到兴奋万分。 充满激情的企业家和有远见的投资者激励着我们，我们也希望成为他们的一员。 我们重视投资的团队并尽全力去帮助和提供可以增加价值的机会。 作为一家全球性企业，凭借多年来积累的多样性和知识性，我们将会为新业务带来全新的视角。 20多年来，我们一直在投资100多家投资组合公司和35家退出公司的风险投资机会，目前正在寻求新的投资机会。 如果您想了解更多信息，请访问我们的网站。
- 网站
-
https://mitsui-global.com/
Mitsui & Co. Global Investment, Inc.的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 11-50 人
- 总部
- Menlo Park，California
- 类型
- 私人持股
- 创立
- 2001
- 领域
- Biotech、Digital Health、Agtech、Foodtech、Fintech和Climatech
地点
Mitsui & Co. Global Investment, Inc.员工
动态
-
Congratulations to the QurAlis team for closing a licensing deal with Eli Lilly for the development of their QRL-204 compound. This compound will potentially restore UNC13a function in patients with ALS and FTD. Amazing work! https://lnkd.in/ePTXJvH9 Kasper Roet Dan Elbaum Angela Genge, MD, FRCP(C), eMBA Vikas Sharma Anne Whitaker Johannes Fruehauf Chris Thomajan Kristine Kelly, MBA Roel Bulthuis Ivan Burkov Jeffrey Moore Peter Wallach Jonathan Behr Kiyoshi Okubo Sunao Nishimura Aya Runderkamp Kazufumi Nakamura Kinji Fuchikami Yukitaka Kojima, CFA Irene Mingozzi Orie Schneider Sue Yasuko Nagakura Makiko Kikuchi Qing (Susie) Shen Yasuhiro S. Atsuko Chitose Michael S. Yu Reiko Namikawa, MD. Ph.D. Yoichiro Miwa Caroline Pinkney
-
Great update from our newest portfolio company, Reunion Neuroscience, who just published results from their preclinical studies. Excellent work and one step further in developing a therapeutic to treat depressive disorders! Welcome to the Mitsui family! Kazufumi Nakamura Yukitaka Kojima, CFAQing (Susie) Shen Kiyoshi Okubo Sunao Nishimura Makiko Kikuchi Aya Runderkamp Orie Schneider Kinji Fuchikami Irene Mingozzi Caroline Pinkney https://lnkd.in/drsquEYU
-
We are happy to announce the closing of Leash Laboratories' seed financing round, one of our newest portfolio companies innovating the drug discovery space. Congratulations to the Leash team! Yukitaka Kojima, CFA